I don’t think anyone is hyped for Breezula - I’d be happy if it got approved soon though as it’s just another option in the very limited arsenal of hairloss treatments with any efficacy.I've lost all interest in Breezula. I'm now focused on Kintor's new topical treatment.
what will be the affinity and potency of pyralutamide compared to RU? is it stronger or weaker?Hands on experience for the last 3 years only. I don't try to save a penny by using mice dosage vs human dosage. I try to go by the patent, trials and other things that bring the tests closer to what the intent is. As soon as you try to optimize and cut corners at the beginning, it is a waste and as you said, people conclude it's not working. Which doesn't bring any advantages trying it in the first place.
if you can't stand the heat, get out of the kitchen
It’s significantly more potent than RU - but we still have yet to see studies proving it’s effectiveness or anecdotes from people experimenting with it. Binding affinity isn’t the only thing that matters.what will be the affinity and potency of pyralutamide compared to RU? is it stronger or weaker?
so what else matters? with agonists there is affinity(how much force attraction is there between the ligand and the receptor) and efficiency(with the induced conformational changes of the ligand receptor complex how many of the receptor related genes are going to get transcriped, how kuch of the receptor is activated), this combined is potency of the agonist. with an antagonist it seems to me that the only important thing is binding affinity and complete imabikity of the complex to bind to a promotor element.It’s significantly more potent than RU - but we still have yet to see studies proving it’s effectiveness or anecdotes from people experimenting with it. Binding affinity isn’t the only thing that matters.
No if it’s much more potent the dose you’ll have to use is much smaller. People on group buys are talking about using something like 0.05mg compared to RU where doses are much higher.so what else matters? with agonists there is affinity(how much force attraction is there between the ligand and the receptor) and efficiency(with the induced conformational changes of the ligand receptor complex how many of the receptor related genes are going to get transcriped, how kuch of the receptor is activated), this combined is potency of the agonist. with an antagonist it seems to me that the only important thing is binding affinity and complete imabikity of the complex to bind to a promotor element.
concentration is also important of course. if i recall correctly RU is delivered in a 5% concentration? is pyralutamide the same concentration?
i also wonder since many have reported sexual sides on RU why would this not happen on pyr if the affinity is higher and the concentration is the same?
No if it’s much more potent the dose you’ll have to use is much smaller. People on group buys are talking about using something like 0.05mg compared to RU where doses are much higher.
I would be sceptical about anyones reports on RU to be honest. There’s a few people on this forum that really know what they are talking about so maybe seek out their experiences with it but obviously any drug in this category could have sexual sides but kintor have said they haven’t seen side effects.
Agreed - they recently got caught lying about the effectiveness of a covid drug that they had in development. Definitely best to just wait and see but it’s still probably one of the more promising upcoming treatments in my opinion.i would nog take their word for it. merck studies also showed very rare sexual sides and no permanent issues, no depression sides in their first fda trial. andthey are not a chinese company known for making their data seem better than it it(kintor covid studies), as long as there is no mechanism for why it should not go systemic i am very sceptic
Yeah the whole “a cure is just 5 years away” thing is a meme now. We’re still stuck using the same sh*t people 20 years ago used.look at this forum, the first few pages. it is one of the promising treatmenrs because there are not many pipelined drugs at all. its basically just kintor that could be reacheable in the next 5 years for US market apporval, everything else is a decade away, peobablx more. completely ridiculous, if you told that to people here iver the years, e. g in 2010 they would not believe it
Based on the quality of your posts, I would not rely on your opinion as the definitive answer. Everything you say on this page as been refuted in the last 79 pages of posts. Do you have Alzheimer?Yeah the whole “a cure is just 5 years away” thing is a meme now. We’re still stuck using the same sh*t people 20 years ago used.
Never said my answer was definitive. What treatment has been approved for hairloss since finasteride?Based on the quality of your posts, I would not rely on your opinion as the definitive answer. Everything you say on this page as been refuted in the last 79 pages of posts. Do you have Alzheimer?
People can’t view your profile or posts.I am hiding what now?
You are losing all your credibility by posting stuff like that. And doing this in the Research section is inconsiderate too.I don’t think anyone is hyped for Breezula - I’d be happy if it got approved soon though as it’s just another option in the very limited arsenal of hairloss treatments with any efficacy.
i mean it is indeed not very promising. insane if you think how long it dates back. to me, this and replicel rch-01 are the greatest dissapointments we have experiencedYou are losing all your credibility by posting stuff like that. And doing this in the Research section is inconsiderate too.
You don’t own this forum other opinions are allowed other than yours.You are losing all your credibility by posting stuff like that. And doing this in the Research section is inconsiderate too.
ah the very famous very scientific research section, popular for none but the greatests insights and discoveries over the last 20 yearsYou are losing all your credibility by posting stuff like that. And doing this in the Research section is inconsiderate too.